SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
8.07
+0.04 (0.50%)
Oct 2, 2026, 4:00 PM EDT - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $686.98 million as of October 2, 2026. Its market cap has increased by 128.44% in one year.
Market Cap
686.98M
Enterprise Value
641.14M
1-Year Change
128.44%
Ranking
Category
Stock Price
$8.07
ChartMarket Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $686.98M, a decrease of -38.68%. That is a compound annual growth rate of -8.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 686.98M | 116.82% |
| Dec 31, 2025 | 316.85M | 55.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Omada Health | 1.25B |
| GoodRx Holdings | 1.12B |
| Teladoc Health | 1.03B |
| HealthStream | 928.89M |
| Phreesia | 643.05M |
| Weave Communications | 590.39M |
| NRC Health | 471.59M |
| Evolent Health | 383.27M |